E-course: Innovations in localised renal cell carcinoma (RCC): From biomarkers and molecular imaging to stereotactic body radiation therapy (SBRT)
This e-course will explore the key innovations in the management of localised renal cell carcinoma (RCC).
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
Through expert insights on stereotactic body radiotherapy (SBRT), biomarkers, and molecular imaging, we aim to clarify how these emerging tools can refine patient selection, improve treatment response assessment, and enhance disease characterisation.
The e-course will address ongoing challenges in integrating novel technologies into clinical pathways and assess whether these approaches are ready for broader implementation.
By bringing multidisciplinary expertise together, this e-course seeks to offer practical answers and perspectives on how to personalise care and push the boundaries of the current RCC management.
Speakers:
- Dr. M.C. Mir Maresma (ES)
- Dr. L. Marandino (GB)
- Dr. G. Francolini (IT)
- Prof. Dr. P. Ost (BE)
- Dr. Z. Tippu (GB)
- Dr. R. Campi (IT)
- Assoc. Prof. D. Amparore (IT)
This e-course is brought to you in collaboration with the EAU Young Urology Office and Young Academic Urologists.